Aims: The aim of this study was to report on the midterm outcomes of patients undergoing percutaneous coronary intervention with bioresorbable vascular scaffolds (BVS) for the treatment o
Boris Schnorbus1,2, MD; Jens Wiebe3, MD; Davide Capodanno4, MD, PhD; Salvatore Brugaletta5, MD; Salvatore Geraci6, MD; Julinda Mehilli7, MD; Azeem Latib8, MD; Maciej Lesiak9, MD; Christoph Jensen10, MD; Alessio Mattesini11, MD; Thomas Münzel1,2, MD; Piera Capranzano3, MD; Carlo Di Mario11, MD; Christoph Naber10, MD; Aleksander Araszkiewicz9, MD; Antonio Colombo8, MD; Giuseppe Caramanno6, MD; Manel Sabate5, MD; Corrado Tamburino4
1. Zentrum für Kardiologie I, Universitätsmedizin Mainz, University Medical Center, German Center for Cardiovascular Research (DZHK, Standort Rhein-Main), Mainz, Germany; 2. Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany;
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
acs/nste-acsbioresorbable scaffoldsnon-st-elevation myocardial infarction (nstemi)st-elevation myocardial infarction (stemi)
Read next articlePrognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome